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We have prepared full-length DNA clones of the Abelson murine leukemia
virus (A-MuLV) genome. A specific probe homologous to the central portion of
the A-MuLV genome was prepared by nick translation of a subcloned restriction
fraction from the cloned DNA. The probe was used to examine the genome
structure of several A-MuLV variants. The conclusions are: (i) three viruses
coding for Abelson-specific proteins of molecular weight 120,000, 100,000, and
90,000 had genomes indistinguishable in size, suggesting that the shorter proteins
are the result of early translational termination; (ii) compared with the genome
encoding the 120,000-dalton (120K) protein, a genome coding for a 160K protein
was 0.8 kilobase larger in the A-MuLV-specific region; and (iii) a genome coding
for a 92K protein had a 700-base pair deletion internal to the coding region. This
mutant was transformation defective: its 92K protein lacked the protein kinase
activity normally associated with the A-MuLV protein, and cells containing the
virus were not morphologically transformed. In addition, we determined the
number of A-MuLV proviruses in each of several transformed fibroblast and
lymphoid cells prepared by infection in vitro. These experiments show that a
single copy of the A-MuLV provirus is sufficient to transform both types of cells
and that nonproducer cells generally have only one integrated provirus.
Abelson murine leukemia virus (A-MuLV) is
a replication-defective, transforming retrovirus
(2). It was derived by passage of the replication-
competent Moloney MuLV (M-MuLV) in mice
(1) and transforms cells of the B-lymphocyte
lineage both in vivo and in vitro (12). In addition,
A-MuLV can transform fibroblastic continuous
cell lines in vitro (15). The RNA genome of A-
MuLV is a hybrid molecule containing portions
of the parental M-MuLV at its ends and a large
central region, termed abl, apparently derived
from a single-copy gene in normal mouse DNA
(4). This genome is only known to code for a
single polypeptide consisting of a portion of the
gag polyprotein of M-MuLV joined to polypep-
tide encoded by the abl sequence. This protein
has a molecular weight of 120,000 in cells con-
taining the prototype strain ofA-MuLV, a strain
that is thus termed A-MuLV(P120) (8, 25). The
protein can be phosphorylated in an in vitro
reaction in which the y-phosphate of ATP is
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transferred to tyrosine residues on the P120
molecule itself (22). In this regard the protein
resembles the smaller pp60src protein encoded
by the Rous sarcoma virus genome (6), and this
similarity between these viruses suggests that
they might transform cells by a common mech-
anism. Indeed, several other transforming ret-
roviruses, such as feline sarcoma virus (3, 20)
and Fujinami virus (H. Hanafusa, personal com-
munication), also encode transforming proteins
associated with tyrosine kinase activity.
The A-MuLV P120 protein contains approxi-
mately 90,000 daltons of protein encoded by the
abl sequence. The intact cellular protein, which
is apparently the product of the abl-related se-
quences in cellular DNA, is a polypeptide of
150,000 molecular weight termed NCP150 (24);
thus, only 60% of the putative original gene
product is contained in the A-MuLV(P120) pro-
tein. Several variants of A-MuLV have been
isolated which produce proteins of sizes different
from that of the P120 molecule (13, 14). Using a
DNA probe specific for abl, we analyzed the
structure of the proviruses in cells infected with
these variants. In all cases examined, the differ-
ences seemed to lie in the abl region of the viral
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genome. These studies define the regions of the
viral protein needed for protein kinase activity
and for cellular transformation. In addition, we
determined the number of proviruses contained
in a variety of cell lines transformed in vitro and
demonstrated that a single provirus is sufficient
for transformation.
MATERIALS AND METHODS
Cells and virus. A-MuLV-transformed NIH/3T3
fibroblast cell lines ANN-1, A2, F1-3, Tx-15, AN-P100,
AN-P90-25, and AN-P90-33 were described previously
(14, 16, 23). The A-MuLV-induced lymphoid line
ABPC-22 (7) was used as a source of virus to derive
the fibroblast line AN-P160-54. The other lymphoid
lines, 18-48 and 2M3, were as described elsewhere
(25). Fibroblast lines were grown in Dulbecco modified
Eagle medium containing 10% calf serum; lymphoid
lines were grown in RPMI 1640 medium containing
10% fetal calf serum and 50 ,uM ,-mercaptoethanol.
M-MuLV was prepared from C1-3A, a clonally in-
fected NIH/3T3 producer cell line.
DNA structure analysis. DNA from tissue culture
lines was prepared after lysis of the cells suspended in
TE buffer (10 mM Tris-chloride, pH 7.5-1mM EDTA)
at 2 x 106 cells/ml by addition of an equal volume of
sodium dodecyl sulfate protease buffer (1% sodium
dodecyl sulfate, 50mM Tris-chloride, pH 7.5, 100mM
NaCl, 10 mM EDTA, and 100 ug of proteinase K per
ml). The lysate was digested for 2 h at 37°C with
gentle mixing and then gently extracted two to three
times with phenol and twice with CHC13. The DNA
was then precipitated by the addition at room tem-
perature of 3 volumes of ethanol. The precipitate was
immediately removed and transferred to TE buffer to
give a final concentration of 200 to 400 ,ug/ml. DNA to
be prepared from liver was made from purified nuclei.
Fresh tissue was minced finely and homogenized in a
tight-fitting Dounce homogenizer in buffer (10 mM
Tris-chloride, pH 7.5-10 mM NaCl-1.5 mM MgC12).
The nuclei were collected by centrifugation, and DNA
was prepared from them as described above for cells.
The DNA (10 ug) for electrophoretic analysis was
incubated in buffer (10 mM Tris-chloride, pH 7.5-50
mM NaCl-6 mM MgC2-0.5 mM dithiothreitol) with
5 U of the appropriate restriction endonuclease (New
England Biolabs) for 2 h at 37°C; an additional 2 U
was added, and digestion was continued for an addi-
tional 2 h. The DNA was then applied to a 0.6%
agarose (Sigma Chemical Co.) gel in TBE buffer (90
mM Tris-hydroxide-90 mM boric acid-9 mM EDTA)
containing ethidium bromide (1 jsg/ml), and electro-
phoresis was carried out at 2 V/cm for 48 h. The gel
was photographed with transillumination by UV light
to ensure that approximately equal quantities ofDNA
were run in each lane. The DNA was denatured and
transferred to nitrocellulose (Millipore Corp.) as de-
scribed (18).
Hybridization to these nitrocellulose sheets was per-
formed by using dextran sulfate as published (21). The
sheets were dried and exposed to XR-5 film at -70°C
with du Pont Lightning Plus screens. Nick translations
ofDNA (9) were carried out by using two a-32P-labeled
deoxyribonucleoside triphosphates (New England Nu-
clear Corp.).
Analysis of 3S-labeled proteins by immunoprecipi-
tation and electrophoresis on polyacrylamide gels was
as previously described (25).
RESULTS
A-MuLV strains. Several variants of A-
MuLV have been detected- since the original A-
MuLV-induced tumor was first isolated. Most of
these variants, arising spontaneously upon
growth of virus-containing cells or upon passage
of virus from A-MuLV producer cells to unin-
fected cells, were detected by virtue of altera-
tions in the size of the A-MuLV-specific protein
(14). A list of the variants known to date, the
size of the protein detected, and their origin is
given in Table 1.
Genome size of A-MuLV variants. To an-
alyze the viral genome in various cell lines, the
DNA provirus was examined. DNA was isolated
from nonproducer cell lines clonally infected
with each of the known variants ofA-MuLV and
was cleaved with either of two enzymes (XbaI
and KpnI) known to cut only in the long terminal
repeat sequences which bracket the integrated
provirus (see reference 4 for a complete restric-
tion map of the A-MuLV genome). Thus, a
proviral DNA fragment was produced free of
adjacent cellular DNA, the length of which
should thus be characteristic of the length of the
provirus. The cleaved DNA was size fractionated
TABLE 1. Properties ofA-MuLV strains and cell
lines
Ref- Protein Genomne
Virus strain Cell line er- pro- size (kb)
A-MuLV(P160) AN-P160-54 12 160K 6.3
298-18
ABPC-22 6
A-MuLV(P120) ANN-i 13 120K 5.5
2M3 10
SWR/4 23
A-MuLV(P100) AN-P100 12 lOOK 5.5
A-MuLV(P90) + AN-P90-25 12 90K 5.5 + 4.0
deletion
A-MuLV(P90) AN-P90-33 90K 5.5
AN-P90-35
234-9
A-MuLV(P9OA) + Late-passage 14 90K + 5.5 + 4.8
A-MuLV(P92td) A2/M 92K
Tx-15 21
A-MuLV(P9OA) AN-P9OA-5 90K 5.5
AN-P90A-21
A-MuLV(P92td) F1-3 21 92K 4.8
F1-6 21
A-MuLV(P90B) + Late-passage 10 90K 5.5 + 4.6
deletion 18-48
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by agarose gel electrophoresis, and the viral
sequences were detected by hybridization with
an A-MuLV-specific DNA probe cloned into
pBR322. This probe, described previously (4),
consists of a 2.5-kilobase (kb) segment of the A-
MuLV genome which lacks any homology to M-
MuLV RNA. Any cellular DNA fragments con-
taining abl-related sequences would also be de-
tected by this probe.
DNA from all cell lines infected with the
different A-MuLV strains was found to contain
new A-MuLV-related fragments as well as those
fragments present in uninfected NIH/3T3 cells
(Fig. 1). Lines infected with A-MuLV(P120) and
A-MuLV(P100) yielded a new viral DNA frag-
ment 5.5 kb in length when the DNA was
cleaved with XbaI (Fig. 1A). An identical new
band was produced by cleavage with KpnI (data
not shown). The genomes encoding the P120
and P100 proteins could thus be unambiguously
identified with the 5.5-kb DNA.
The cloned cell line (AN-P90-25) producing
P90 contained two new fragments: one 5.5 kb
and one 4.0 kb (Fig. 1A). The genome encoding
the P90 protein could be either of these. To
identify the genome of the A-MuLV(P90) strain,
virus was rescued from line AN-P90-25 by su-
perinfection with M-MuLV helper and used to
clonally infect NIH/3T3 cells. New nonproducer
transformed cell lines were isolated from this
infection, and DNA from them was analyzed as
before (Fig. 1B). These lines, all producing P90
protein, now contained only a 5.5-kb genome.
Thus, like the A-MuLV(P120) and A-
MuLV(P100) strains, the A-MuLV(P90) strain
was represented by a 5.5-kb XbaI fragment.
Further analyses using another restriction en-
donuclease, SacI (data not shown), showed that
two intemal DNA fragments were also indistin-
guishable in all three strains. Thus, no gross
change was detected in the genome size or or-
ganization that could be responsible for the al-
tered size ofthe protein encoded by these strains.
We have never observed passage of the 4.0-kb
FIG. 1. Analysis ofproviral DNAs contained in various A-MuLV-infected cells. (A) DNAs isolated from
the indicated cell lines were cleaved with XbaI to release most of the linearprovirus (from the site in left long
terminal repeat to the site in the right long terminal repeat) from the flanking sequences. The DNAs were
displayed on a 0.6%o agarose gel, blotted, and hybridized with an A-MuL V-specificprobe (plasmidpAB3Sub3;
4). Those fragments present in uninfected cell DNA are marked "C", the sizes of proviral fragments, as
determined from DNA markers ofknown size, are shown. (B) DNAs from the indicated cell lines were cleaved
with XbaI and analyzed as in (A). (C) DNAs from the indicated cell lines were cleaved with KpnI and
analyzed as in (A).
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DNA fragment present in AN-P90-25 to other
cells; preliminary mapping (data not shown) sug-
gests that this is a defective provirus ofA-MuLV
not bracketed by two complete long terminal
repeats.
Cleavage with the enzyme KpnI demonstrated
that cell lines producing the P160 A-MuLV-spe-
cific protein had a viral genome approximately
6.3 kb long (Fig. 1C) or 800 base pairs (bp) larger
than the A-MuLV(P120) 5.5-kb genome. The
fragment was also produced by cleavage with
XbaI, but comigrated with a fragment from the
cellular gene. The viral fragment could be de-
tected only by the increase in intensity of label-
ing relative to that of the uninfected NIH/3T3
cell DNA (see Fig. 3).
Analysis of A2 cell DNA and virus. The
nonproducer cell line A2 was derived by low-
multiplicity infection of NIH/3T3 cells with a
mixed virus stock containing A-MuLV and M-
MuLV helper (16). The cell line at that time
produced A-MuLV-specific proteins of two sizes
(25): the normal P120 protein and a second
protein of approximately 92,000 molecular
weight which we now term P92. During passage,
however, production ofthe larger protein ceased,
and only A-MuLV-specific polypeptides approx-
imately 90,000 daltons in size could be detected.
This cell line, after the change in expression had
occurred, was used as a source ofvirus to prepare
molecular clones of the A-MuLV genome (4).
These experiments resulted in the isolation of
two sets of clones: clones containing a full-length
genome and shorter clones containing a 700-bp
deletion in the abl region. It seemed likely that
the A2 cell line contained two proviruses.
This explanation was confirmed by direct
analysis of DNA from an early passage of A2
cells. Digestion with XbaI showed the presence
of two fragments (Fig. 1C). One was 5.5 kb, like
those proviral fragments in cells producing P120,
P100, or P90; the other was 4.8 kb. An identical
pattern was found in a late-passage strain of A2
cells that had been superinfected with M-MuLV
(A2/M cells); in this strain the change of P120
expression to P90 expression had occurred. We
conclude that two proviral genomes were pres-
ent in A2 cells and that the alteration that
occurred during the switch from P120 to P90
production was not detectable as a size change
in the A-MuLV DNA.
Isolation of new virus strains producing
P90 and P92, a defective transforming pro-
tein. To separate the two viruses in A2 cells, the
virus rescued from the cells was used to infect
NIH/3T3 cells (multiplicity of infection of 0.3
focus-forming units/cell), and the cells were
cloned in microtiter dishes immediately after
infection. After 10 days, the cloned cell lines
were scored for the presence of helper virus and
for the transformed morphology characteristic
of Abelson-infected NIH/3T3 cells.
Twenty nonproducer clones with a grossly
transformed morphology were examined for the
size of their A-MuLV proviral DNA. All clones
contained the larger A-MuLV viral genome (Fig.
2A shows 11 of these). Many, but not all, of
these clones also contained the smaller viral
genome; those clones with the small provirus
were indistinguishable in morphology from
clones not carrying the small provirus. We con-
clude that the large genome was sufficient for
effecting morphological transformation of these
cells and that the small viral genome present in
A2 cells was not essential for the process. All
clones tested produced an A-MuLV-specific pro-
tein of approximately 90,000 daltons, confirming
that the larger genome in A2 cells encoded this
protein. We term this protein P9OA to distin-
guish it from another 90,000-molecular-weight
variant isolated independently (see Table 1).
The protein size and the genome size of these
independently arising A-MuLV strains were in-
distinguishable.
From the cell lines infected with A2-derived
virus, 18 morphologically normal clones were
screened for the presence of A-MuLV-specific
protein by immunoprecipitation. As expected,
most were apparently uninfected; two cell lines,
however, were detected which produced a
92,000-molecular-weight A-MuLV-specific pro-
tein. Analysis of the DNA of these cell lines
revealed that only the smaller viral genome was
present. An example of one of the lines, F1-3, is
shown in Fig. 2B; one of the morphologically
transformed clones containing both proviruses,
isolated from the same infection, Tx-15, is shown
for comparison. Thus, the deleted genome was
defective for morphological transformation of
NIH/3T3 cells; we therefore tern this viral
strain A-MuLV(P92td). Further analysis of the
activity of this protein indicated that the protein
kinase activity associated with other A-MuLV
proteins was lacking in this protein (23). Circular
DNA from the A-MuLV(P92td) strain has been
molecularly cloned, and the 700-base deletion
has been localized to the 5' half of the abl region
(4; see Fig. 6).
Genome structure of proviruses in
lymphoid cells. To examine the genome struc-
ture of the A-MuLV variants in transformed
lymphoid cells, DNA was isolated from a variety
of cloned cell lines prepared by infection of bone
marrow cells in vitro. The DNAs were cleaved
with XbaI and KpnI as before to release a pro-
viral DNA fragment whose size was character-
istic of the viral strain. The DNA was separated
by electrophoresis and hybridized with the abl
VOL. 38, 1981
464 GOFF ET AL.
FIG. 2. Identification of the two genomes cloned from A2 cells. (A) The DNAs were isolated from morpho-
logically transformed cell lines clonally infected with virus rescued from A2 cells. DNA from each cell line
was cleaved with XbaI, displayed on an agarose gel, blotted, and hybridized as in Fig. 1. The DNA fragments
present in uninfected cells are marked "C"; the sizes of the two A-MuLV proviruses are shown. (B) DNAs
from the indicated cell lines were cleaved with XbaI and processed as in (A).
probe. In all cases (Fig. 3A), the genome size was
identical to that of the virus used to infect the
cells.
The intensity of hybridization to the proviral
DNA, in comparison with the hybridization to
the endogenous cellular DNA fragments, sug-
gested that these cells contained only a single
provirus. To determine the number ofproviruses
more accurately, the DNAs were cleaved
with enzymes which do not cut within the pro-
virus; thus, the size of the provirus-containing
DNA fragment produced should depend on the
arrangement of restriction endonuclease cleav-
age sites in the cell DNA flanking the provirus.
Previous work with other retroviruses has shown
that they integrate into so many different sites
that cutting outside the proviral DNA produces
distinguishable fragment sizes from independent
integration events (19). All of the A-MuLV-
transformed lymphoid cells lines examined had
only a single provirus-containing fragment after
cleavage with EcoRI (Fig. 3B). Similar results
were obtained after cutting the DNA with XhoI
(data not shown). We conclude that the virus
strains producing P90, P120, or P160 are all
capable of transforming lymphoid cells without
alteration in genome structure and by integra-
tion of only a single provirus.
Viral genomes in 18-48 cells. Examination
of one transformed lymphoid cell line yielded a
more complicated pattern. The virus-producing
cell line 18-48 was prepared by infection of bone
marrow cells in vitro with the P120 strain of A-
MuLV, and it originally made P120 (25). After
long-term passage, however, the line began to
produce smaller A-MuLV-specific proteins
(100,000 to 90,000 molecular weight) as well as
the P120. Analysis of the DNA revealed two
classes of proviruses: a provirus 5.5 kb in size,
identical to that coding for the P120 or P90
proteins, and a second band 4.6 kb in length
(Fig. 4). To determine which genome encoded
the A-MuLV proteins, culture medium was har-
vested and used to clonally infect NIH/3T3 fi-
J. VIROL.













FIG. 3. Analysis of proviral DNAs in lymphoid cell lines. (A) DNAs from the indicated cell lines were
cleaved with Xbal, separated by electrophoresis, and hybridized with the abl-specific probe. The genome sizes
are marked. (B) DNAs from the indicated cell lines were cleaved with EcoRI to release a fragment whose size
was deternined by the celular sequences flanking the provirus. The DNAs were separated by electrophoresis
and analyzed as in Fig. 1.
broblasts. Six morphologically transformed
clones were isolated and examined for the size
of the A-MuLV-specific protein and the size of
the A-MuLV provirus. All lines produced only a
90,000-molecular-weight protein termed P9OB to
distinguish it from the other independent pro-
teins of this size (Fig. 5), and all contained only
the 5.5-kb provirus (data not shown). We were
not able to rescue the 4.6-kb provirus. We con-
clude that 18-48 originally contained an active
P120 provirus 5.5 kb in length. During passage
the virus switched to producing P9OB without
gross genomic changes, much as A2 cells did.
Like A2 cells, 18-48 also carries a smaller pro-
virus, but unlike that of A2 cells, this provirus
apparently cannot be rescued and may not code
for protein.
DISCUSSION
A remarkable number of active A-MuLV
strains has been identified (14) which produce
Abelson-specific proteins of different sizes (Ta-
ble 1). The genome sizes of these viral strains
have now been determined and are summarized
in Fig. 6. The largest genome, 6.3 kb in length,
codes for the largest Abelson protein, P160. This
strain is found in cell lines made with virus
originating in the laboratories of W. Rowe and
M. Potter at the National Institutes of Health
(7) and is widely used as a wild-type virus. A 5.5-
VOL. 38, 1981
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FIG. 4. Analysis of provirus in 18-48 cells. DNAs
fr-om late-passage 18-48 cells, NIH/3T cells, and
late-passage A2/M cells were cleaved with XbaI and
analyzed a-s before. The sizes of the proviral DNAs
are marked.
kb genome, encoding the P120 protein, is found
in the ANN-i cell line and in most lines trans-
formed by virus rescued from ANN-1. This
strain is the wild-type virus from our laboratory.
The genealogy of these strains is obscure: it
seems likely that the P160 genome was the orig-
inal isolate which subsequently suffered a dele-
tion of 800 bp to give rise to the shorter P120
genome. We cannot rule out the possibility, how-
ever, that the P120 strain was the original virus
and gave rise to the larger genome by a dupli-
cation or an insertion of 800 bp. There could
even have been multiple A-MuLV's in the orig-
inal isolate. Preliminary mapping (S. Latt, S. P.
Goff, and D. Baltimore, unpublished data)
places the difference between these strains near
the center of the virus, within the portion of the
abi region which encodes the protein. It should
be noted that the difference in the size of the A-
MuLV genomes roughly accounts for the differ-
ence in the size of the proteins. Thus, it is
probable that the extra sequences of the P160
strain are translated in phase and that termina-
tion occurs at the same point as in the P120
strain. Other models are possible, and the differ-
ence between these genomes may be more com-
plicated. We are currently constructing molecu-
lar clones of the A-MuLV(P160) genome to test
these notions.
Viral genomes encoding two proteins of still
smaller size, P100 and P90, had no detectable
alterations from the 5.5-kb parent which pro-
duces P120. Thus, these two genomes probably
contain point mutations or very small deletions
(<50 bp) undetectable by our techniques. More
complicated alterations such as inversions or
combined deletions/duplications which do not
change the size ofXbaI, KpnI, or SacI restriction
fragments would also have escaped detection.
We propose that the proteins lack the C-terni-
nal region of the P120 protein; either nonsense
mutations cause early chain termination, or un-
detectably small alterations change translational
reading frames and cause termination soon
tGi?A6 AG IA DG00 A G A
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FIG. 5. Electrophoretic analysis of the A-MuLV-
specific proteinsproduced by clones ofNIH/3T3 cells
infected with late-passage 18-48 virus. Extracts from
each line, labeled with [35SJmethionine, were immu-
noprecipitated with (lanes G) goat anti-MuLV anti-
serum (20) or (lanes A) mouse anti-AbT sera (1), and
the precipitated proteins were separated on a 10%
polyacrylamide gel and visualized by fluorography.
Each clone contained an A-MuL V-specific protein of
90,000 daltons.
J. VIROL.

















































Q ! 2 3 4 5 6 ki mapping of this 700-bp deletion (4) places the
alteration within the region normally encoding
5 3' the P120 protein; moreover, the size of the dele-
tion accounts for the smaller size of the P92
NHY * OH protein. The deletion therefore probably does
not disturb the translational reading frame and
K= allows read-through to a termination codon at
NH2,* COOH the normal position. The region deleted corre-
sponds to a stretch of amino acids 50,000 to
NHab*COQH 78,000 daltons from the N terminus of the P120.
,H-, Whereas the C-terminal 30,000 daltons of pro-
K171_tein is apparently dispensible for at least some
NH COOH of the P120 function [as shown by the A-
yr. MuLV(P90) strains], this internal region cannot
be removed without complete loss of function.
NH,' * COOH It is worth noting the surprising plasticity of
6. Structure ofA-MuLV genomes. The open the A-MuLV protein and its remarkable ability
represent M-MuLV-specific regions (MOL), to retain at least some function even after the
e shaded regions are the abi sequences for five loss of large segments of protein. If the P160
,nt A-MuLV strains. The dark line under each protein is assumed to be the true parental viral
entedgenome shows the region encoding the A- protein, then 70,000 daltons-more than half of
'polyptide. Theposition ofthe sequence miss- the 120,000 to 130,000 daltons encoded by the
aU strain except the A-MuLV(P160) is not abl region-is dispensible. Perhaps virus-in-
accurately and is desigated by a broken duced transfonnation requires only one of the
n. The position of the additional deketion functions normally performed by this cellularin the A-MuLV(P92td) strain is marked by a protein. No mutations have yet been found in
riangle. the gag-specific portion of the Abelson protein;
after. If this is the correct interpretation, the function performed by this region is there-
-terminal 30,000 daltons of the P120 is fore unknown.
cessary for the morphological transforma- Many of the viral variants isolated were de-
if fibroblasts. It should be noted that it has rived after passage of virus stocks to fresh cells
shown that the P90 virus, while retaining (e.g., those in A2 cells). These mutations prob-
of its transforming activity, has a reduced ably arose upon reverse transcription of viral
y to transform lymphoid cells (14) and also RNA or at some other early stage of infection
reduced activity in the in vitro protein (17). Many others arose by spontaneous muta-
e activity as compared with the P120 pa- tion in integrated proviruses during cell passage
l strain (13). In spite of these defects, when (e.g., those viruses coding for the P100 and P90
iLV(P90) does successfully transform proteins). The appearance of these variants is
hoid cells, it accomplishes the feat with unexpected since mutations arising in proviruses
a single integrated provirus (Fig. 3). The depend on errors occurring during cell passage
tion which gave rise to the P90 protein probably during cell-directed DNA replication;
rently can occur with a high frequency be- this should be a very infrequent event. These
two other independent events yielded an mutants may have been exposed inadvertently
rently identical variant, the P9OA strain to a selective pressure that favored the accu-
I in late-passage A2 cells and the P9OB mulation of rare variants. It is possible, for ex-
i found in late-passage 18-48 cells. ample, that the presence of full-length P120
)bably the most ificant viral strain an- protein is deleterious to the growth of fibroblasts
d here is the transformation-defective virus in a way that the P90 and P100 proteins are not.
iLV(P92td). NIH/3T3 cell lines carrying Lymphoid cell lines derived by in vitro infec-
irus do not show the characteristic trans- tion of bone marrow cells apparently carry pro-
,d morphological changes of other A- viruses whose size (characteristic of the A-
V-transformed lines (23). The virus is un- MuLV strain) is identical to that of the provi-
to transform lymphoid cells in vivo or in ruses in fibroblast lines. Thus, although the suc-
,and the P92 protein produced has no as- cessful transformation of bone marrow cells is
ted protein kinase activity, although this less efficient than that of NIH/3T3 cells (10), no
in can act as an acceptor for phosphate if gross alteration of viral structure is required to
I with a wild-type A-MuLV protein (23). effect the rarer event. In most cases examined,
leletion within this strain suggests that the the cells carry a single provirus, proving that a
protein is essential for transformation. The single integration event can suffice to transform
VOL. 38, 1981
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and immortalize the cell. Similar results have
been obtained from analyses of the avian sar-
coma proviruses (5). Thus, the requirement for
specific helper viruses for A-MuLV lymphoid
cell transformation (11) cannot be a consequence
of the helper catalyzing multiple integrations of
the A-MuLV genome.
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